Accuracy of Information given by ChatGPT for Patients with Inflammatory Bowel Disease in Relation to ECCO Guidelines
View abstract on PubMed
Summary
This summary is machine-generated.Artificial intelligence (AI) platforms like ChatGPT can answer patient questions about inflammatory bowel disease (IBD). While generally accurate, AI responses may lack completeness and deviate from expert guidance in specialized areas.
Area Of Science
- Medical Informatics
- Artificial Intelligence in Healthcare
- Gastroenterology
Background
- Growing patient acceptance of artificial intelligence (AI) platforms necessitates evaluating their reliability as information sources.
- The accuracy and completeness of ChatGPT3.5 for inflammatory bowel disease (IBD) queries are currently unknown.
- Understanding AI's capabilities in IBD is crucial for patient education and clinical support.
Purpose Of The Study
- To prospectively assess the accuracy and completeness of ChatGPT3.5 responses to patient-generated questions on inflammatory bowel disease (IBD).
- To compare AI-generated answers against established European Crohn's and Colitis Organisation (ECCO) guidelines.
- To evaluate AI performance across different IBD-related topics, including Crohn's disease, ulcerative colitis, malignancy, maternal medicine, infection, vaccination, and complementary medicine.
Main Methods
- Thirty-eight IBD patient-generated questions were inputted into ChatGPT3.5.
- Responses were evaluated for accuracy (1-5 scale) and completeness (1-3 scale) by 14 expert gastroenterologists.
- Data analysis included comparisons with relevant ECCO guidelines and statistical tests (Kruskal-Wallis) to assess variations across question categories and individual questions.
Main Results
- Most ChatGPT3.5 responses demonstrated high accuracy (84.2% median score ≥4), with a mean accuracy score of 3.87.
- Completeness scores were lower, with a mean rating of 2.24; 34.2% of responses achieved a median completeness score of 3.
- Significant variations in accuracy and completeness were found across individual questions (p<0.001), with smoking-related queries scoring highest and malignancy/vaccination queries scoring lowest.
Conclusions
- ChatGPT3.5 shows capability in providing accurate answers to real-world IBD patient queries, suggesting potential as a supplementary tool.
- AI-generated responses may deviate from evidence-based guidelines in specialized areas and require more definitive advice.
- Further research is needed to refine AI's role in IBD patient care, ensuring it complements, rather than replaces, standard medical advice.
Related Concept Videos
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Assessing the gastrointestinal (GI) system is a complex process that begins with collecting subjective data. This data, collected through patient interviews, provides crucial insights into the patient's health history, perception patterns, and lifestyle habits, all contributing significantly to GI health.
Health History
The initial step in assessing the GI system is obtaining a comprehensive health history. This includes inquiring about the patient's history or presence of problems...
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

